Postnatal Expansion of the Pancreatic β-Cell Mass Is Dependent on Survivin
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
OBJECTIVE—Diabetes results from a deficiency of functional β-cells due to both an increase in β-cell death and an inhibition of β-cell replication. The molecular mechanisms responsible for these effects in susceptible individuals are mostly unknown. The objective of this study was to determine whether a gene critical for cell division and cell survival in cancer cells, survivin, might also be important for β-cells. RESEARCH DESIGN AND METHODS—We generated mice harboring a conditional deletion of survivin in pancreatic endocrine cells using mice with a Pax-6-Cre transgene promoter construct driving tissue-specific expression of Cre-recombinase in these cells. We performed metabolic studies and immunohistochemical analyses to determine the effects of a mono- and biallelic deletion of survivin. RESULTS—Selective deletion of survivin in pancreatic endocrine cells in the mouse had no discernible effects during embryogenesis but was associated with striking decreases in β-cell number after birth, leading to hyperglycemia and early-onset diabetes by 4 weeks of age. Serum insulin levels were significantly decreased in animals lacking endocrine cell survivin, with relative stability of other hormones. Exogenous expression of survivin in mature β-cells lacking endogenous survivin completely rescued the hyperglycemic phenotype and the decrease in β-cell mass, confirming the specificity of the survivin effect in these cells. CONCLUSIONS—Our findings implicate survivin in the maintenance of β-cell mass through both replication and antiapoptotic mechanisms. Given the widespread involvement of survivin in cancer, a novel role for survivin may well be exploited in β-cell regulation in diseased states, such as diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![FIG. 4. Loss of islet cell mass and nuclear abnormalities in survivin-deficient mice. A: Expansion of the endocrine cell mass after birth. Pancreatic tissue was isolated from age-matched animals at the indicated times. The mean (± SD) islet cell mass of control (▪, n = 8 [P0], 3 [P7], 5 [P14], 4 [P21], and 4 [8W]) and survivin-deficient (□, n = 7 [P0], 3 [P7], 5 [P14], 4 [P21], and 4 [8W]) tissues was calculated by point morphometry. *Significant (P < 0.001) difference. B: β-Cell size differences in affected animals. Pancreatic tissue isolated from animals at the indicated times was stained with H-E and visualized by light microscopy. Mutant β-cells with enlarged nuclei are indicated by arrows. Bars = 20 μm. C: Nuclear size measurements from B. ▪, control tissue (n = 5); □, survivin-deficient tissue (n = 5). *Significance at P < 0.001. (Please see http://dx.doi.org/10.2337/db08-0170 for a high-quality digital representation of this image.)](https://figures.cochat.ai/paper-figures/f3d1f316f1dc47d0826359337d483aec/postnatal-expansion-of-the-pancreatic-cell-mass-is-dependent-on-survivin-figure-4.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Birc5-deficient animals progressively lose β-cell mass after 2 weeks of age, and Birc5-deficient cells exhibit dysmorphic nuclei, consistent with defective cell division [59].”
From Expansion of β-cell mass in response to pregnancy (2010) · cites this paper as [59]
In the citing paper
“A recent study showed a bifunctional role for Birc5 (survivin), controlling both proliferation and inhibition of apoptosis specifically in the β-cell in vivo [59].”
From Expansion of β-cell mass in response to pregnancy (2010) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651 · cited 1×
“p21 protein, within a family of proteins that also includes p27 and p57, can function to inhibit (47-49) cyclin-dependent kinases leading to a decrease in the rate of cell cycle progression.”
BackgroundThe retinoblastoma protein and cell cycle control
Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90385-2 · Cited by 4,862
Generalized lacZ expression with the ROSA26 Cre reporter strain
Soriano, P. (1999) · Nature Genetics · doi:10.1038/5007 · Cited by 4,859 · cited 1×
“RESEARCH DESIGN AND METHODS Pax6-Cre mice (also called Le-Cre) were crossed with B6;129S-Gtrosa26 mice to evaluate Cre activity (29).”
MethodStöckl, S., Göttl, C., Grifka, J., & Grässel, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350089 · Cited by 4,656
A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
Ambrosini, G., Adida, C., & Altieri, D. C. (1997) · Nature Medicine · doi:10.1038/nm0897-917 · Cited by 3,165 · cited 1×
“Survivin was originally discovered as a homolog to the inhibitor of apoptosis proteins in cancer cells (14).”
BackgroundSelf-citationAdult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation
Dor, Y., Brown, J., Martinez, O. I., & Melton, D. A. (2004) · Nature · doi:10.1038/nature02520 · Cited by 2,219
G 1 Events and Regulation of Cell Proliferation
Pardee, A. B. (1989) · Science · doi:10.1126/science.2683075 · Cited by 2,182
DNA damage-induced cell death by apoptosis
Roos, W. P., & Kaina, B. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.07.007 · Cited by 1,500 · cited 1×
“In addition, pancreas tissue from the Cdk4-null mice show evidence of both a decrease in -cell proliferation and an increase in apoptosis (40), the latter likely induced after activation of a cell cycle checkpoint in response to a lack of cell cycle progression (47).”
BackgroundAdvances in Male Contraception
Page, S. T., Amory, J. K., & Bremner, W. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0041 · Cited by 1,134
Cited by
Type 1 Diabetes: Etiology, Immunology, and Therapeutic Strategies
Van Belle, T. L., Coppieters, K. T., & Von Herrath, M. G. (2011) · Physiological Reviews · doi:10.1152/physrev.00003.2010 · Cited by 1,022
Structural similarities and differences between the human and the mouse pancreas
Dolenšek, J., Rupnik, M. S., & Stožer, A. (2015) · Islets · doi:10.1080/19382014.2015.1024405 · Cited by 348
Expansion of β-cell mass in response to pregnancy
Rieck, S., & Kaestner, K. H. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2009.11.001 · Cited by 358
Marselli, L., Thorne, J., Dahiya, S., Sgroi, D. C., Sharma, A., Bonner-Weir, S., Marchetti, P., & Weir, G. C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011499 · Cited by 313
“Survivin enhances proliferation and survival of cancer cells and seems to have similar effects upon beta-cells [50].”
Self-citationThe transcriptional response of the islet to pregnancy in mice
Rieck, S., White, P., Schug, J., Fox, A. J., Smirnova, O., Gao, N., Gupta, R. K., Wang, Z. V., Scherer, P. E., Keller, M. P., et al. (2009) · Molecular Endocrinology · doi:10.1210/me.2009-0144 · Cited by 160
“Conditional deletion of Birc5, an inhibitor of apoptosis, specifically in the endocrine pancreas, showed a severe inability to maintain normal postnatal ß-cell mass throughout adulthood in vivo (15).”
Background
Metadata
- Authors
- Jiang, Y., Nishimura, W., Devor-Henneman, D., Kusewitt, D., Wang, H., Holloway, M. P., Dohi, T., Sabo, E., Robinson, M. L., Altieri, D. C., Sharma, A., & Altura, R. A.
- Affiliations
- Nationwide Children's Hospital (US)
- Joslin Diabetes Center (US)
- The Ohio State University (US)
- Brown University (US)
- University of Massachusetts Chan Medical School (US)
- Miami University (US)
- Corresponding author
- Altura, Rachel A.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2008-10-01
- Volume
- 57
- Issue
- 10
- Pages
- 2718-2727
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC2551682
- OpenAlex
- W2116245644
- Cited by
- 38
- References
- 58
- Citations by year
- 2024: 1 · 2022: 3 · 2020: 2 · 2017: 3 · 2015: 2 · 2014: 3 · 2013: 6 · 2012: 4
- FWCI
- 4.92
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Funders
- National Heart, Lung, and Blood Institute (R01HL054131, R37HL054131, HL 54131)
- National Cancer Institute (R01CA078810, CA-78810, R01CA090917, CA-90917)
- National Institute of Diabetes and Digestive and Kidney Diseases (R21DK078300, DK060127, R01DK060127, 1R21-DK-078300-01)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Keywords
- survivin, pancreatic beta cells, beta-cell mass, postnatal development, conditional gene deletion, type 1 diabetes, hyperglycemia, insulin deficiency, beta-cell proliferation, beta-cell apoptosis, anti-apoptotic mechanisms, pancreatic endocrine cells
- MeSH terms
- Survivin, Animals, Diabetes Mellitus, Type 1, Female, Glucagon, Immunohistochemistry, Insulin, Islets of Langerhans, Male, Mice, Inbred Strains, Mice, Transgenic, Microtubule-Associated Proteins, Repressor Proteins, Somatostatin, Gene Deletion, Insulin-Secreting Cells, Inhibitor of Apoptosis Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.